Upper GI Cancer Research Review, Issue 10
In this issue:
FRUTIGA: fruquintinib + paclitaxel for advanced gastric/GOJ adenocarcinoma
Claudin18.2-specific CAR T-cell therapy in GI cancers
Neoadjuvant nivolumab ± relatlimab in resectable oesophageal/GOJ cancer
TOPAZ-1: durvalumab + gemcitabine-cisplatin in advanced biliary tract cancer
ATTRACTION-5: adjuvant nivolumab + chemotherapy for resected stage 3 gastric/GOJ cancer
NALIRICC: nanoliposomal irinotecan + fluorouracil + leucovorin in biliary tract cancer
EPIC: early palliative care for metastatic upper GI cancers & OS
Long-term discontinuation vs. continuation of imatinib for advanced GIST
T-DXd in HER2-positive/HER2-low biliary tract cancer
Pertuzumab + trastuzumab in biliary tract cancer with HER2/3 alterations
Expert contributor
Dr Pei Ding
Dr Pei Ding is a medical oncologist and trialist at Westmead Hospital Crown Princess Mary Cancer Centre and Nepean Hospital Cancer and Wellness Centre, with clinical expertise in managing lung and gastrointestinal cancers. She completed her fellowship and PhD study in lung cancer liquid biopsy research at the Ingham Institute of Applied Medical Research and […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.